CPRX stock-based compensation history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Catalyst Pharmaceuticals Inc Stock-Based Compensation — Trailing twelve months (TTM) (USD)
Period ending	Stock-Based Compensation (USD)
Mar 31, 2026	25,188,000
Dec 31, 2025	24,778,000
Sep 30, 2025	24,288,000
Jun 30, 2025	23,042,000
Mar 31, 2025	19,853,000
Dec 31, 2024	22,251,000
Sep 30, 2024	21,330,000
Jun 30, 2024	20,716,000
Mar 31, 2024	19,606,000
Dec 31, 2023	14,250,000
Sep 30, 2023	11,926,000
Jun 30, 2023	10,171,000
Mar 31, 2023	8,896,000
Dec 31, 2022	7,907,000
Sep 30, 2022	7,453,000
Jun 30, 2022	6,910,000
Mar 31, 2022	6,405,000
Dec 31, 2021	6,073,000
Sep 30, 2021	6,070,264
Jun 30, 2021	4,558,264
Mar 31, 2021	4,834,726
Dec 31, 2020	3,263,726
Sep 30, 2020	1,794,462
Jun 30, 2020	2,611,522
Mar 31, 2020	1,742,056
Dec 31, 2019	2,675,467
Sep 30, 2019	3,705,088
Jun 30, 2019	3,646,204
Mar 31, 2019	3,512,715
Dec 31, 2018	3,550,644
Sep 30, 2018	3,006,533
Jun 30, 2018	2,778,095
Mar 31, 2018	2,625,157
Dec 31, 2017	2,407,961
Sep 30, 2017	2,411,096
Jun 30, 2017	2,413,560
Mar 31, 2017	2,132,260
Dec 31, 2016	1,836,085
Sep 30, 2016	1,923,782
Jun 30, 2016	1,722,350
Mar 31, 2016	1,728,976
Dec 31, 2015	1,585,458
Sep 30, 2015	1,296,759
Jun 30, 2015	1,410,615
Mar 31, 2015	1,069,290
Dec 31, 2014	777,969
Sep 30, 2014	532,876
Jun 30, 2014	134,915
Mar 31, 2014	157,233
Dec 31, 2013	175,855
Sep 30, 2013	337,579
Jun 30, 2013	336,499
Mar 31, 2013	336,701
Dec 31, 2012	340,039
Sep 30, 2012	384,688
Jun 30, 2012	388,088
Mar 31, 2012	408,074
Dec 31, 2011	416,735
Sep 30, 2011	413,794
Jun 30, 2011	400,781
Mar 31, 2011	421,493
Dec 31, 2010	450,089
Sep 30, 2010	523,384
Jun 30, 2010	562,767
Mar 31, 2010	541,511
Dec 31, 2009	601,438
Sep 30, 2009	999,729
Jun 30, 2009	924,374
Mar 31, 2009	859,842
Dec 31, 2008	980,972
Sep 30, 2008	819,747
Jun 30, 2008	819,747
Mar 31, 2008	819,747
Dec 31, 2007	756,711
Sep 30, 2007	200,368
Jun 30, 2007	200,368